Loading...
Market
What percentage of patients will have stable vision improvement one year post-treatment by end of 2025?
2
Resolution / Starting Odds
0-25% • 25%
26-50% • 25%
51-75% • 25%
76-100% • 25%
Scientific publications or official reports from Osaka University
Story
Osaka University Researchers Restore Vision in Four Patients with Limbal Stem Cell Deficiency Using Stem Cells
Nov 9, 2024, 02:36 PM
Researchers from Osaka University have achieved a significant breakthrough in treating blindness caused by limbal stem cell deficiency (LSCD) using induced pluripotent stem cells (iPSCs). In a first-of-its-kind interventional study conducted in Japan, the team performed corneal transplant surgery on four patients, with promising results. The study, which was a single-arm, open-label trial, demonstrated rapid vision improvement in all patients post-transplant, with their improved vision remaining stable over time. Notably, only one patient experienced a decline in vision during the initial year following the procedure. This innovative approach marks a pivotal advancement in regenerative medicine and offers new hope for individuals suffering from LSCD.
View original story
Similar markets
0-5 patients • 25%
6-10 patients • 25%
11-15 patients • 25%
More than 15 patients • 25%
0-10 patients • 25%
11-20 patients • 25%
21-30 patients • 25%
More than 30 patients • 25%
Less than 50% • 25%
50% - 60% • 25%
60% - 70% • 25%
More than 70% • 25%
Below 80% • 25%
80% to 85% • 25%
85% to 90% • 25%
Above 90% • 25%
Less than 50% • 25%
50% to 74% • 25%
75% to 80% • 25%
More than 80% • 25%
Europe • 25%
Asia • 25%
South America • 25%
No expansion • 25%
Age-related macular degeneration • 25%
Diabetic retinopathy • 25%
Retinitis pigmentosa • 25%
No other application • 25%
Less than 25% • 25%
25% to 50% • 25%
51% to 75% • 25%
More than 75% • 25%
Confirms significant risk • 25%
No significant risk found • 25%
Inconclusive results • 25%
Study retracted • 25%
Less than 40% • 25%
40% to 60% • 25%
61% to 80% • 25%
More than 80% • 25%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
Less than 50% • 25%
50% to 70% • 25%
71% to 90% • 25%
More than 90% • 25%